New Research on PCA3 and T2-ERG Tests

Good news- more research on non-invasive testing for prostate cancer:

http://www.cancernetwork.com/prostate-cancer/content/article/10165/2027790

Initial results of a multicenter trial show that 2 biomarkers, PCA3 and T2-ERG, are found at high levels in prostate cancer compared to noncancerous prostate cells and correlate well with 2 indicators of aggressive prostate cancer, tumor volume and Gleason score. This study was conducted by researchers from the Fred Hutchinson Cancer Research Center, Stanford University, and Beth Israel Deaconess Medical Center, among others.

 

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.